BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11895758)

  • 21. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
    Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
    Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Martín-Palanco V; Martín-Subero JI; San José-Eneriz E; Garate L; Álvarez S; Miranda E; Rodríguez-Otero P; Rifón J; Torres A; Calasanz MJ; Cruz Cigudosa J; Román-Gómez J; Prósper F
    PLoS One; 2011 Feb; 6(2):e17012. PubMed ID: 21386967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of cyclin-dependent kinase inhibitors in leukemia].
    Polák J; Peková S; Schwarz J; Kozák T; Haskovec C
    Cas Lek Cesk; 2003 Jan; 142(1):25-8. PubMed ID: 12693294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of P21(WAF1/CIP1/SID1) cyclin-dependent kinase inhibitor in hematopoietic progenitor cells.
    Campanini F; Santucci MA; Brusa G; Pattacini L; Arpinati M; Rondelli D; Gamberi B; Barbieri E; Babini L; Tura S
    Gene; 2001 Aug; 273(2):173-80. PubMed ID: 11595163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
    Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
    Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia.
    Mai H; Liu X; Chen Y; Li C; Cao L; Chen X; Chen S; Liu G; Wen F
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):497-504. PubMed ID: 26501552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications.
    Wong IH; Ng MH; Huang DP; Lee JC
    Blood; 2000 Mar; 95(6):1942-9. PubMed ID: 10706859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.
    Agirre X; Román-Gómez J; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Navarro G; Vázquez I; Zalacain M; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Oncogene; 2006 Mar; 25(13):1862-70. PubMed ID: 16314841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.
    Zhang W; Kornblau SM; Kobayashi T; Gambel A; Claxton D; Deisseroth AB
    Clin Cancer Res; 1995 Sep; 1(9):1051-7. PubMed ID: 9816079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
    Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
    Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.
    Schafer E; Irizarry R; Negi S; McIntyre E; Small D; Figueroa ME; Melnick A; Brown P
    Blood; 2010 Jun; 115(23):4798-809. PubMed ID: 20215641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
    Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
    J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis.
    Marks DI; Kurz BW; Link MP; Ng E; Shuster JJ; Lauer SJ; Brodsky I; Haines DS
    Blood; 1996 Feb; 87(3):1155-61. PubMed ID: 8562942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
    Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM
    Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF; Ng IO
    Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.